Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage

Journal of Surgical Research

Volumn 192, Issue 1, 2014, Pages 206-213

  Zhang, Xiang Sheng ^a   Zhang, Xin ^a   Wu, Qi ^a   Li, Wei ^a   Wang, Chun Xi ^a   Xie, Guang Bin ^a   Zhou, Xiao Ming ^a   Shi, Ji Xin ^a   Zhou, Meng Liang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Astaxanthin; Early brain injury; Inflammation; Subarachnoid hemorrhage

Indexed keywords

ASTAXANTHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; NEUROPROTECTIVE AGENT; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER DISRUPTION; BRAIN EDEMA; BRAIN INJURY; BRAIN WATER; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; ENCEPHALITIS; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; LOW DRUG DOSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUTROPHIL; NICK END LABELING; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SUBARACHNOID HEMORRHAGE; ANIMAL; CELL DEATH; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MALE; METABOLISM; NEURITIS; OPTIC CHIASM; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CELL DEATH; DISEASE MODELS, ANIMAL; INTERLEUKIN-1BETA; MALE; NEURITIS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OPTIC CHIASM; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; TUMOR NECROSIS FACTOR-ALPHA; XANTHOPHYLLS;

EID: 84921734262     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.05.029     Document Type: Article

References (31)

1. Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 2012;97:14.
2. Sehba FA, Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 2011;43:27.
3. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006;26:1341.
4. Sozen T, Tsuchiyama R, Hasegawa Y, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009;40:2519.
5. Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 2006;28:399.
6. Luo C, Yi B, Tao G, et al. Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhage. Neuroreport 2010;21:892.
7. Lin TY, LuCW,Wang SJ. Astaxanthininhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependentCa(2+) entry andmitogen-activated protein kinase signaling pathway. J Agric Food Chem2010;58:8271.
8. Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003;21:210.
9. Shen H, Kuo CC, Chou J, et al. Astaxanthin reduces ischemic brain injury in adult rats. Faseb J 2009;23:1958.
10. Lee DH, Lee YJ, Kwon KH. Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J Clin Biochem Nutr 2010; 47:121.
11. Zhang XS, Zhang X, Zhou ML, et al. Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage. J Neurosurg 2014;121:42.
12. Wang Z, Shi XY, Yin J, Zuo G, Zhang J, Chen G. Role of autophagy in early brain injury after experimental subarachnoid hemorrhage. J Mol Neurosci 2012;46:192.
13. You WC, Li W, Zhuang Z, et al. Biphasic activation of nuclear factor-kappa B in experimental models of subarachnoid hemorrhage in vivo and in vitro. Mediators Inflamm 2012; 2012:786242.
14. Li H, Wu W, Sun Q, et al. Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage. Brain Res 2014;1543:315.
15. Wang JW, Wang HD, Cong ZX, et al. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J Surg Res 2014;186:328.
16. Zhuang Z, Zhou ML, You WC, et al. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci 2012;13:47.
17. Chen CC, Hung TH, Wang YH, et al. Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-kappaB signaling after experimental traumatic brain injury. PLoS One 2012;7:e30294.
18. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 1998;18:3251.
19. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A. A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008;39: 2578.
20. Greenhalgh AD, BroughD, Robinson EM, Girard S, Rothwell NJ, Allan SM. Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech 2012;5:823.
21. Jiang Y, Liu DW, Han XY, et al. Neuroprotective effects of anti-tumor necrosis factor-αlpha antibody on apoptosis following subarachnoid hemorrhage in a rat model. J Clin Neurosci 2012;19:866.
22. Fassett RG, Coombes JS. Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiol 2009;5:333.
23. Kim YJ, Kim YA, Yokozawa T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J Agric Food Chem 2009;57:8793.
24. Fassett RG, Coombes JS. Astaxanthin in cardiovascular health and disease. Molecules 2012;17:2030.
25. Ohgami K, Shiratori K, Kotake S, et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 2003;44:2694.
26. Ikeda Y, Tsuji S, Satoh A, Ishikura M, Shirasawa T, Shimizu T. Protective effects of astaxanthin on 6- hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 2008;107:1730.
27. Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol 2008;60:1365.
28. Chan KC, Mong MC, Yin MC. Antioxidative and antiinflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. J Food Sci 2009;74:H225.
29. Lee SJ, Bai SK, Lee KS, et al. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol Cells 2003;16:97.
30. Suzuki Y, Ohgami K, Shiratori K, et al. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway. Exp Eye Res 2006;82:275.
31. Terazawa S, Nakajima H, Shingo M, Niwano T, Imokawa G. Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletionindependent manner. Exp Dermatol 2012;21(Suppl 1):11.